Patient Information Leaflet Drug interaction with ED drug treatments



Similar documents
HELPFUL TIPS WHEN FACING CHRONIC HEPATITIS C

CIALIS (See-AL-iss) (tadalafil) tablets

Drug/Drug and Drug/Food Interactions with Target-Specific Oral Anticoagulants

862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians

Daclatasvir (Daklinza)

Adherence to oral cancer therapies

The Novel Oral Anticoagulants

Erectile Dysfunction (ED)

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

Interactions with COUMADIN

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) Tablets

Bristol-Myers Squibb and Gilead Sciences, LLC 50

Shaun Mickus Phone: Mobile: om

Harvoni (Ledipasvir/Sofosbuvir) Treatment Agreement

Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets

Marketplace Health Plans Template Assessment Tool October 2014

Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC

Novel oral anticoagulants (NOACs): novel problems and their solutions

Novel Oral Anticoagulants (NOACs) Prescriber Update 2013

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV

Trileptal (Oxcarbazepine)

Os Novos Anticoagulantes não são necessários

Perspective Hepatitis C Virus Direct-Acting Antiviral Drug Interactions and Use in Renal and Hepatic Impairment

Sudden dizziness, trouble walking, loss of balance or coordination

HIV 1. A reference guide for prescription HIV-1 medications

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Drug Treatment Program Update

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Package leaflet: Information for the user. CIALIS 20 mg film-coated tablets Tadalafil

Managing Drug Interactions in Transplant Recipients

My remarks today and the information contained in these slides do not necessarily reflect the official views of FDA.

ANTICOAGULANT DRUG INTERACTIONS. New Agents, New Concerns

News Release. Media Contacts: Kristina Chang Tel: (908) Mobile: (201)

Helpful HIV Medication Tables for Pharmacists

Novel Anticoagulants: Case of Mr. T

State Health Reform Impact Modeling Project Tennessee

DOSAGE FORMS AND STRENGTHS HIGHLIGHTS OF PRESCRIBING INFORMATION

Recovery of Erectile Function After Radical Prostatectomy Vanderbilt University Department of Urologic Surgery

Comprehensive Case Management Reassessment

TSOAC Initiation Checklist

X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal

STATE HEALTH REFORM IMPACT MODELING PROJECT. Alabama

continuing education for pharmacists

Practical How-to: Treating Patients with New Anticoagulants case scenarios

State Health Reform Impact Modeling Project Florida

Covered California s 2016 Formularies

November 6, A listing of the data presentations is included below:

CHAPTER 2B HIV DRUG-DRUG INTERACTIONS I. INTRODUCTION GENERAL RECOMMENDATIONS:

Alpha-Blocker Patient Advisory ASCRS and AAO Information Statement

New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO Saturday, 26 September :17

Package leaflet: Information for the user. Norvir 100 mg film-coated tablets ritonavir

RIVAROXABAN. Consumer Information

Translating clinical evidence into real-world outcomes

Real-World Data Confirms Safety and Efficacy Profile of XARELTO, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

Statin Safety 2014 NLA Update

FAST FACTS. About XARELTO (rivaroxaban) in Reducing the Risk of Stroke in Patients with Atrial Fibrillation. About AFib

Clinically Significant Cardiovascular. Drug Interactions. April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist

Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

MEDICAL THERAPY OF ED Ian Eardley

Erectile Dysfunction Agents Step Therapy Criteria

sexual after Being prostate cancer... Manitoba Prostate Centre Visit our website at

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE

Coadministered Agent Dosage atazanavir 300 mg orally once daily

B.C. HIV/AIDS Drug Treatment Program

South CarolinaJanuary 2013

More information for patients and caregivers can be accessed at

Drug-Drug Interactions with Antiretroviral Therapy. Case-Based Discussions

Summary of the risk management plan (RMP) for Cerdelga (eliglustat)

STATE HEALTH REFORM IMPACT MODELING PROJECT. North Carolina

New Jersey. State Health Reform Impact Modeling Project

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

CICLOSPORIN. What are the aims of this leaflet?

PATIENT JOURNAL. XARELTO CarePath. Total Hip Replacement. Useful information for before, during and after surgery

Clinical Criteria for Hepatitis C (HCV) Therapy

News Release. Media Contacts: Kristina Chang Tel: (908) Mobile: (201)

Evaluating Drugs Used to Treat: Enlarged Prostate. Comparing Effectiveness, Safety, and Price

Treatment Information Service HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition

District of Columbia

Maryland. State Health Reform Impact Modeling Project

Opioid Pain and Addiction Management Medications Drug. Interactions with HIV Antiretrovirals. A Drug Interaction Guide for Clinicians.

Sexual Dysfunction and DIABETES in Men

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014

High Cholesterol and Heart Disease

MEDICAL ASSISTANCE BULLETIN

Slide 1. Slide 2. Slide 3. Disclosures. Objectives DRUG INTERACTIONS WITH NEW ORAL ANTICOAGULANTS. None

o pain, aching, or tenderness on the right o loss of appetite

**Form 1: - Consultant Copy** Telephone Number: Fax Number: Author: Dr Bernard Udeze Pharmacist: Claire Ault Date of issue July 2011

WORST PILLS BEST PILLS

HIGHLIGHTS OF PRESCRIBING INFORMATION

STATE HEALTH REFORM IMPACT MODELING PROJECT. Georgia

How To Get A Tirf

DVT/PE Management with Rivaroxaban (Xarelto)

Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions

Request for Prior Authorization HEPATITIS C TREATMENTS

PULMONARY ARTERIAL HYPERTENSION AGENTS

Contents What are side effects? Why do I need to know about side effects of HIV medications?

Prior Authorization of buprenophine/naloxone (Suboxone ) or buprenorphine (Subutex )

See 17 for PATIENT COUNSELING INFORMATION Risk of Priapism: In the event that an erection lasts more than 4 hours, the

Amlodipine 5 and 10 mg tablets

Transcription:

Patient Information Leaflet Drug interaction with ED drug treatments This document is intended for information purposes only and should be used in conjunction with the advice and further details to be discussed by Mr. Ahmed at your consultation meeting. Watch out for Interactions Between Drugs for Erectile Dysfunction and Other Medications Anyone with a television probably knows that three prescription medications currently are used to treat erectile dysfunction (ED): sildenafil (VIAGRA), tadalafil (CIALIS) and vardenafil (LEVITRA). These drugs, which belong to the class of drugs called phosphodiesterase 5 inhibitors (PDE5i), are widely used, especially in older men. And because older men are more likely to be concurrently taking other medications, they should be aware of the potential for dangerous interactions when ED drugs are mixed with other prescription drugs. This article deals only with these three approved prescription ED drugs, not the many untested ED products widely advertised on the Internet and elsewhere (see Tables 1, 2, and 3). How do ED drugs interact? Sildenafil, tadalafil and vardenafil are drugs that cause the dilation of blood vessels (vasodilators) and this effect can be magnified when they are used with other medications with similar vasodilating effects. It is this vasodilating effect that increases blood flow to the penis causing an erection. Most ED drug interactions, however, result from the fact that these drugs are metabolized by the enzyme CYP3A4 in the intestine and liver. CYP3A4 is the most important enzyme for drug metabolism, and many medications can interact with ED drugs by decreasing or increasing CYP3A4 activity, causing ED drug levels to increase or decrease, respectively. Interactions with vasodilators People who take nitrates (drugs commonly used to dilate the blood vessels in the heart for patients with coronary artery disease, such as nitroglycerin, also Poppers ), either on a regular schedule or as needed, should not use these ED drugs. A dangerous reduction in blood pressure may occur, potentially leading to a heart attack or stroke, and so these drugs should not be used in combination. ED drugs also can enhance the blood pressure lowering effects of alpha blockers such as doxazosin (CARDURA), prazosin (MINIPRESS), terazosin (HYTRIN), tamsulosin (FLOMAX) and alfuzosin (UROXATRAL).. These drugs are used to treat both high blood pressure and enlarge prostate glands. If you are on an alpha blocker, consult your physician before taking an ED drug; he or she may recommend dosage adjustments or other precautions. Interactions with drugs that decrease CYP3A4 activity Drugs that inhibit CYP3A4 can substantially increase plasma concentrations of ED drugs, potentially leading to toxicity. See Table 2 for a list of drugs that inhibit CYP3A4. If you are taking any of these drugs, check with your physician before taking an ED drug. Your physician may advise a dosage reduction of the ED drug, especially if you are taking a potent CYP3A4 inhibitor such as ketoconazole, itraconazole or ritonavir. Keep in mind that grapefruit juice is also a CYP3A4 inhibitor. Interactions with drugs that increase CYP3A4 activity Drugs that increase CYP3A4 activity (see Table 3) tend to reduce the effect of ED drugs. This is not dangerous, of course, but it may render the ED drug ineffective. If the increased CYP3A4 activity is marked such as in patients taking the antibiotic rifampin, even the highest Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 1 of 6

recommended dose of the ED drug may be ineffective. Again, if you are taking any of the medications in Table 3, talk to your physician before starting an ED drug so he or she will know that the effect of the ED drug may be compromised. (See Tables 1, 2 and 3 on Page 3.) What You Can Do Many medications have the potential to interact with ED drugs, so it is important to make sure that the physician prescribing the ED drug is aware of all the other medications you are taking. If you start or stop other medications after receiving a prescription for an ED drug, check to make sure your ED drug effect will not increase or decrease as a result. Table 1. List of Drugs That May Cause Excessive Decreases in Blood Pressure When Taken with ED Drugs Isosorbide dinitrate Isosorbide mononitrate Nitroglycerin DILATRATE-SR, ISORDIL, SORBITRATE IMDUR, ISMO, MONOKET MINITRAN, NITRO-BID, NITRO-DUR, NITROSTAT, TRANSDERM- NITRO Alpha Blockers Nitrates Generic Name BRAND NAME(may be the brand name is different. Always check on the label for the generic name if not sure) Generic Name Doxazosin Prazosin BRAND NAME CARDURA MINIPRESS Terazosin HYTRIN Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 2 of 6

Cyclosporine NEORAL, Tamsulosin FLOMAX SANDIMMUNE Alfuzosin UROXATRAL Darunavir PREZISTA Dasatinib SPRYCEL Table 2. Drugs That May Cause ED Drug Toxicity by Decreasing CYP3A4 Activity Delavirdine RESCRIPTOR Generic Name BRAND NAME Diltiazem CARDIZEM, CARDIZEM CD, DILACOR XR, TIAZAC Amprenavir AGENERASE Aprepitant EMEND Erythromycin EES, ERYTHROCIN Atazanavir REYATAZ Fluconazole DIFLUCAN Clarithromycin BIAXIN Fluvoxamine LUVOX Conivaptan VAPRISOL Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 3 of 6

Fosamprenavir LEXIVA Posaconazole NOXAFIL Grapefruit Juice Quinupristin SYNERCID Imatinib GLEEVEC Ritonavir NORVIR Indinavir CRIXIVAN Saquinavir FORTOVASE, INVIRASE Itraconazole SPORANOX Telithromycin KETEK Ketoconazole NIZORAL Troleandomycin TAO Lapatinib TYKERB Verapamil CALAN, CALAN SR, COVERA-HS, Mifeprestone MIFEPREX ISOPTIN, ISOPTIN SR, VERELAN Nefazodone SERZONE Voriconazole VFEND Nelfinavir VIRACEPT Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 4 of 6

Zafirlukast ACCOLATE Efavirenz SUSTIVA PLEASE DO NOT STOP ANY OF THESE Modafinil PROVIGIL DRUGS WITHOUT CONSULTING WITH YOUR DOCTOR. Nafcillin NALLPEN, UNIPEN Table 3. Drugs That May Inhibit the Effect of ED Drugs by Increasing CYP3A4 Activity Nevirapine VIRAMUNE Oxcarbazepine TRILEPTAL Generic Name BRAND NAME Phenobarbital LUMINAL, Aminoglutethimide CYTADREN SOLFOTON Bosentan TRACLEER Primidone MYSOLINE Carbamazepine CARBATROL, Phenytoin DILANTIN TEGRETOL Rifabutin MYCOBUTIN Dexamethasone DECADRON, HEXADROL, MYMETHASONE Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 5 of 6

Rifampin RIFADIN, RIMACTANE Rifapentine PRIFTIN St. John s wort Disclaimer: This document is for information only and should not be used for the diagnosis or treatment of medical conditions. Urology and Healthcare has used all reasonable care in compiling the information but make no warranty as to its accuracy. Urology and Healthcare is the trading name of Urology and Healthcare Ltd. Drug interaction with ED drug treatments (UH08) V1.2 Mar 2012 Page 6 of 6